Table 3 Clinical measures at baseline and follow-up by group, absolute values
Pathology tests | Baseline | Endpoint (excluding 22 lost to follow up) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Control n = 113 | Intervention n = 100 | Control n = 107 | Intervention n = 84 | |||||||||
No. | Mean | SD | No. | Mean | SD | No. | Mean | SD | No. | Mean | SD | |
HbA1c | 113 | 10.6 | 1.87 | 99 | 10.8 | 2.0 | 105 | 10.3 | 2.2 | 84 | 9.8 | 2.3 |
s.creatinine | 97 | 77.5 | 43.8 | 88 | 77.7 | 39.7 | 102 | 92.0 | 85.0 | 83 | 107.4 | 138.6 |
eGFR* | 97 | 109.8 | 26.7 | 88 | 114.1 | 31.0 | 102 | 104.5 | 30.8 | 83 | 103.3 | 33.4 |
UACR | 78 | 63.9 | 138.9 | 73 | 71.3 | 169.4 | 96 | 102.8 | 233.9 | 79 | 92.1 | 167.9 |
Cholesterol | 87 | 4.6 | 1.3 | 81 | 4.5 | 1.3 | 100 | 4.7 | 1.3 | 79 | 4.4 | 1.4 |
Trig | 86 | 2.5 | 1.9 | 81 | 2.1 | 1.4 | 100 | 2.7 | 1.8 | 79 | 2.5 | 1.8 |
HDL | 72 | 1.1 | 0.6 | 79 | 0.9 | 0.2 | 99 | 0.9 | 0.2 | 78 | 0.9 | 0.2 |
LDL | 65 | 2.6 | 1.0 | 76 | 2.7 | 1.1 | 95 | 2.6 | 1.1 | 71 | 2.4 | 0.9 |
Chol-HDL ratio | 72 | 5.2 | 1.6 | 77 | 5.4 | 1.6 | 99 | 5.0 | 1.4 | 77 | 5.0 | 1.7 |
Weight | 89 | 91.4 | 19.3 | 87 | 89.7 | 22.6 | 92 | 87.4 | 18.6 | 81 | 91.0 | 23.1 |
BP systolic | 109 | 134.0 | 20.9 | 95 | 127.9 | 16.7 | 100 | 133.6 | 19.4 | 84 | 132.5 | 17.7 |
BP diastolic | 104 | 81.0 | 11.1 | 92 | 77.7 | 10.4 | 103 | 81.3 | 11.4 | 84 | 77.8 | 9.9 |